Clinical Trial Update: A Study of DC-CIK to Treat Hepatocellular Carcinoma [Phase 2]

View source ↗

Summary

This document reports a Phase 2 clinical trial update of DC-CIK therapy for hepatocellular carcinoma, with the trial status currently listed as UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• DC-CIK therapy (dendritic cell-cytokine-induced killer cells)

Snippet

Sponsor: Guangxi Medical University | Conditions: Hepatocellular Carcinoma (HCC) | Phase 2 | Status: UNKNOWN